This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
SIRI co-creator Babak Hodjat, now CTO of AI at Cognizant, shares insights on AI’s evolution and how Cognizant is building powerful agents for Fortune 500 firms.